Journal rankings · indicator year 2005
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2005
Endocrinology, Diabetes and Metabolism journal rankings 2005
70 ranked journals · Subfield in Medicine
Endocrinology, Diabetes and Metabolism has 70 ranked journals in 2005. The median OJR rose 0.11 on 2004 to 0.81, below the world average of 1.00; Q1 starts at OJR 1.29. The top three are Endocrine Reviews, Diabetes Care, and The Journal of Clinical Endocrinology & Metabolism.
Ranks and citation indicators: 2005. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2002–2004, the window the 2005 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery409
- Pulmonary and Respiratory Medicine172
- Public Health, Environmental and Occupational Health145
- Cardiology and Cardiovascular Medicine139
- Oncology120
- Infectious Diseases92
- Epidemiology91
- Psychiatry and Mental health87
- Radiology, Nuclear Medicine and Imaging81
- Neurology76
- Physiology72
- Endocrinology, Diabetes and Metabolism70
Show all 42 subfields
- Orthopedics and Sports Medicine54
- Pediatrics, Perinatology and Child Health52
- Dermatology49
- Hematology48
- Ophthalmology46
- Obstetrics and Gynecology41
- Rheumatology32
- Nephrology31
- Pharmacology31
- Complementary and alternative medicine25
- Reproductive Medicine25
- Emergency Medicine23
- Geriatrics and Gerontology19
- Otorhinolaryngology17
- Pathology and Forensic Medicine17
- Rehabilitation17
- Critical Care and Intensive Care Medicine13
- Immunology and Allergy12
- Hepatology9
- Genetics8
- Anesthesiology and Pain Medicine6
- Gastroenterology6
- Urology6
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
70 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2004. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2002–2004, the window the 2005 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2002–2004 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2000 to 2005. | Compare |
|---|---|---|---|---|---|---|---|
1Endocrine ReviewsOxford University Press · United States | 7.31Q1 | 22.17 4.80 up from 2004 | 153 | 25% | $3,750 | ||
2Diabetes CareAmerican Diabetes Association · United States | 2.83Q1 | 7.08 0.69 up from 2004 | 2,012 | 58% | — | ||
3The Journal of Clinical Endocrinology & MetabolismOxford University Press · United States | 2.35Q1 | 6.70 0.93 up from 2004 | 2,941 | 30% | $3,750 | ||
4Endocrine Related CancerBioscientifica · United Kingdom | 2.35Q1 | 5.69 0.11 up from 2004 | 139 | 68% | — | ||
5DiabetologiaSpringer Science+Business Media · Germany | 2.29Q1 | 5.42 0.05 down from 2004 | 807 | 91% | $3,490 | ||
6Endocrinology and Metabolism Clinics of North AmericaElsevier BV · United States | 2.02Q1 | 5.48 1.49 up from 2004 | 149 | 3% | $3,540 | ||
7Journal of Internal MedicineWiley · United Kingdom | 1.89Q1 | 4.42 0.71 up from 2004 | 473 | 62% | $4,780 | ||
8EndocrinologyOxford University Press · United States | 1.77Q1 | 5.47 0.84 up from 2004 | 2,392 | 31% | $3,750 | ||
9Best Practice & Research Clinical Endocrinology & MetabolismElsevier BV · United Kingdom | 1.75Q1 | 4.13 0.38 up from 2004 | 122 | 2% | $4,450 | ||
10Clinical TherapeuticsElsevier BV · United States | 1.75Q1 | 3.52 0.47 up from 2004 | 628 | 5% | $4,240 | ||
11Cardiovascular DiabetologyOABioMed Central · United Kingdom | 1.58Q1 | 3.72 0.56 up from 2004 | 34 | 100% | $4,290 | ||
12Menopause The Journal of The North American Menopause SocietyLippincott Williams & Wilkins · United States | 1.50Q1 | 3.86 1.20 up from 2004 | 260 | 3% | — | ||
13The Aging MaleOAInforma · United Kingdom | 1.47Q1 | 3.09 0.13 down from 2004 | 67 | 81% | $2,557 | ||
14Diabetes/Metabolism Research and ReviewsWiley · United Kingdom | 1.40Q1 | 3.02 1.74 down from 2004 | 239 | 8% | $4,780 | ||
15Diabetic MedicineWiley · United Kingdom | 1.39Q1 | 3.26 0.35 up from 2004 | 738 | 8% | $4,870 | ||
16Journal of EndocrinologyBioscientifica · United Kingdom | 1.38Q1 | 3.52 0.28 down from 2004 | 677 | 93% | — | ||
17European Journal of EndocrinologyOxford University Press · United Kingdom | 1.35Q1 | 3.71 0.23 up from 2004 | 659 | 12% | $4,292 | ||
18Clinical EndocrinologyWiley · United Kingdom | 1.29Q1 | 3.44 0.46 up from 2004 | 720 | 12% | $4,250 | ||
19Diabetes & MetabolismElsevier BV · Netherlands | 1.25Q2 | 2.93 0.77 up from 2004 | 182 | 7% | $4,490 | ||
20Reviews in Endocrine and Metabolic DisordersSpringer Science+Business Media · Netherlands | 1.15Q2 | 2.68 0.39 up from 2004 | 114 | 0% | $5,590 | ||
21Current Diabetes ReportsSpringer Science+Business Media · United States | 1.11Q2 | 3.05 0.74 up from 2004 | 211 | 2% | $4,890 | ||
22Growth Hormone & IGF ResearchElsevier BV · United Kingdom | 1.10Q2 | 2.90 0.45 up from 2004 | 158 | 6% | $3,570 | ||
23Diabetes Obesity and MetabolismWiley · United Kingdom | 1.07Q2 | 2.59 0.49 down from 2004 | 260 | 8% | $5,380 | ||
24Journal of Diabetes and its ComplicationsElsevier BV · United States | 1.03Q2 | 2.17 0.30 down from 2004 | 191 | 0% | $3,760 | ||
25Hormone Research in PaediatricsKarger Publishers · Switzerland | 0.96Q2 | 2.22 0.19 down from 2004 | 455 | 23% | — | ||
26Clinical cornerstoneElsevier BV · Netherlands | 0.91Q2 | 1.79 0.63 up from 2004 | 87 | 0% | — | ||
27Lipids in Health and DiseaseOABioMed Central · United Kingdom | 0.91Q2 | 1.59 1.01 down from 2004 | 44 | 100% | $2,990 | ||
28Endocrine PracticeElsevier BV · United States | 0.90Q2 | 2.15 0.56 up from 2004 | 263 | 1% | $3,480 | ||
29ThyroidMary Ann Liebert, Inc. · United States | 0.90Q2 | 2.08 0.42 down from 2004 | 481 | 4% | — | ||
30MaturitasElsevier BV · Netherlands | 0.89Q2 | 2.13 0.23 up from 2004 | 469 | 19% | $4,390 | ||
31ClimactericTaylor & Francis · United Kingdom | 0.86Q2 | 2.35 0.95 up from 2004 | 153 | 6% | — | ||
32Pediatric DiabetesWiley · Denmark | 0.85Q2 | 1.99 1.21 up from 2004 | 108 | 40% | $2,740 | ||
33EndocrineSpringer Science+Business Media · United States | 0.85Q2 | 2.05 0.05 down from 2004 | 328 | 5% | $3,090 | ||
34Diabetes Research and Clinical PracticeElsevier BV · Netherlands | 0.84Q2 | 1.84 0.25 down from 2004 | 483 | 12% | $4,410 | ||
35Diabetes Technology & TherapeuticsMary Ann Liebert, Inc. · United States | 0.83Q2 | 2.29 0.42 up from 2004 | 244 | 5% | — | ||
36Hormone and Metabolic ResearchThieme Medical Publishers (Germany) · Germany | 0.80Q3 | 1.73 0.17 down from 2004 | 485 | 3% | — | ||
37PeptidesElsevier BV · United States | 0.78Q3 | 2.32 0.40 down from 2004 | 869 | 7% | $3,710 | ||
38PituitarySpringer Science+Business Media · Netherlands | 0.72Q3 | 1.39 0.16 up from 2004 | 99 | 0% | $4,490 | ||
39Journal of Endocrinological InvestigationSpringer Science+Business Media · Italy | 0.68Q3 | 1.59 0.06 up from 2004 | 592 | 3% | $4,790 | ||
40Nutrition Metabolism and Cardiovascular DiseasesElsevier BV · Italy | 0.63Q3 | 1.46 0.40 up from 2004 | 100 | 3% | $3,000 | ||
41Journal of Diabetes ResearchOAHindawi Publishing Corporation · United Kingdom | 0.58Q3 | 1.38 0.08 down from 2004 | 70 | — | $2,760 | ||
42Acta DiabetologicaSpringer Science+Business Media · Germany | 0.55Q3 | 1.22 0.44 up from 2004 | 164 | 0% | $4,590 | ||
43Endocrine PathologySpringer Science+Business Media · United States | 0.54Q3 | 1.21 0.35 down from 2004 | 118 | 5% | $3,190 | ||
44The Science of Diabetes Self-Management and CareSAGE Publishing · United States | 0.54Q3 | 1.65 0.67 up from 2004 | 135 | 4% | $4,400 | ||
45Journal of Pediatric Endocrinology and MetabolismDe Gruyter · Germany | 0.52Q3 | 1.09 0.05 down from 2004 | 491 | 1% | $2,712 | ||
46Endocrine JournalOAJapan Endocrine Society · Japan | 0.52Q3 | 1.27 0.20 up from 2004 | 286 | 50% | — | ||
47Clinical Drug InvestigationAdis, Springer Healthcare · New Zealand | 0.46Q3 | 1.08 0.13 up from 2004 | 278 | 1% | $4,190 | ||
48Endocrine ResearchTaylor & Francis · United States | 0.42Q3 | 0.92 0.24 down from 2004 | 229 | 8% | — | ||
49Current Opinion in Endocrinology & DiabetesLippincott Williams & Wilkins · United States | 0.40Q3 | 0.47 0.47 down from 2004 | 125 | 0% | — | ||
50Clinical DiabetesAmerican Diabetes Association · United States | 0.38Q3 | 0.78 0.02 up from 2004 | 109 | 63% | — |
Subfields of Medicine, with Endocrinology, Diabetes and Metabolism highlighted.
- Surgery409
- Pulmonary and Respiratory Medicine172
- Public Health, Environmental and Occupational Health145
- Cardiology and Cardiovascular Medicine139
- Oncology120
- Infectious Diseases92
- Epidemiology91
- Psychiatry and Mental health87
- Radiology, Nuclear Medicine and Imaging81
- Neurology76
- Physiology72
- Endocrinology, Diabetes and Metabolism70
- Orthopedics and Sports Medicine54
- Pediatrics, Perinatology and Child Health52
- Dermatology49
- Hematology48
- Ophthalmology46
- Obstetrics and Gynecology41
- Rheumatology32
- Nephrology31
- Pharmacology31
- Complementary and alternative medicine25
- Reproductive Medicine25
- Emergency Medicine23
- Geriatrics and Gerontology19
- Otorhinolaryngology17
- Pathology and Forensic Medicine17
- Rehabilitation17
- Critical Care and Intensive Care Medicine13
- Immunology and Allergy12
- Hepatology9
- Genetics8
- Anesthesiology and Pain Medicine6
- Gastroenterology6
- Urology6
- Internal Medicine3
- Transplantation2
- Biochemistry1
- Family Practice1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2005. Corpus-wide, 70.9% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
24 additional Endocrinology, Diabetes and Metabolism journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2002–2004, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2005. Publication window: 2002–2004. How these summaries are calculated
- Ranked journals
- 70
- Window papers (baseline)
- 30,069 +16.5% from indicator year 2002
- Median OJR
- 0.81 +18.0% from indicator year 2002
- Rising journals (2025)
- 11
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2002–2004 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 48 | 51 | 57 | 60 | 65 | 70 | 78 | 84 | 89 | 95 | 101 | 111 | 124 | 132 | 136 | 141 | 151 | 156 | 162 | 168 | 161 | 163 | 159 | 159 | 157 | 152 | |
| Window papers (baseline) | 21,857 | 24,171 | 25,806 | 27,521 | 27,880 | 30,069 | 32,732 | 36,738 | 40,740 | 46,752 | 50,540 | 53,888 | 54,290 | 56,103 | 58,424 | 61,715 | 64,393 | 66,581 | 68,391 | 70,385 | 72,729 | 75,894 | 79,750 | 82,000 | 83,560 | 87,039 | |
| Median OJR | 0.50 | 0.65 | 0.69 | 0.77 | 0.71 | 0.81 | 0.84 | 0.94 | 0.91 | 0.93 | 1.01 | 0.959 | 0.98 | 0.868 | 0.97 | 0.957 | 0.951 | 0.893 | 0.950 | 0.86 | 0.954 | 0.8896 | 0.8903 | 0.9170 | 0.9165 | 0.870 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.